News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Accenture and Bristol-Myers Squibb Company (BMY) Launch Pharmaceutical Industry's First Joint Center for Pharmacovigilance


9/13/2007 10:15:38 AM

NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) and Bristol-Myers Squibb Company (NYSE: BMY) today launched in Chennai, India, the pharmaceutical industry’s first joint center for pharmacovigilance. Pharmacovigilance is the monitoring of safety data to ensure optimal use of medicines. It entails the capture, assessment, and reporting of potential side effects to medicines.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES